Stress erythropoiesis is a critical area within hematology that focuses on the body's response to increased demand for red blood cell production, often ...

Erythroblasts possess unique characteristics as they undergo differentiation from hematopoietic stem cells. During terminal erythropoiesis, these cells incorporate large amounts of iron in order to ...

Anaemia in myelofibrosis is a multifaceted challenge with a significant impact on patient outcomes, writes Theresa Lowry ...

"When begun early in the disease course, luspatercept may help to delay the need for [red blood cell] transfusions," the ...

Patients with symptomatic anaemia associated with chronic kidney disease who are on chronic maintenance dialysis can now also ...

Transplant is beneficial earlier in life, Wang told MedPage Today, but carries potential short- and long-term side effects.

Anemia is more common in later-stage chronic kidney disease (CKD), with diabetes and dialysis increasing the risk. Treating the underlying cause can improve symptoms and quality of life. It’s ...

Keros Therapeutics is a clinical-stage biopharmaceutical company focusing on rare and hematological diseases. Read why I rate KROS stock a Hold now.

Although erythropoiesis-stimulating agents can boost hemoglobin levels, they also elevate the risk for major cardiovascular events, adding to the challenge of managing anemia in patients with CKD ...

Therapeutics announced that in late November U.S. Renal Care enrolled the first patient in its Vafseo Outcomes In-Center ...

GSK has made the decision to withdraw Jesduvroq (daprodustat) from the US market. Approved in 2023, Jesduvroq, (HIF-PHI), is ...

The global cancer supportive care drugs market is crucial in enhancing the quality of life and managing symptoms for cancer ...